India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

India Juris Supports USD 2.5 Million Seed Investment in AI

USD 15 Million Funding Round Advised by India Juris

India Juris – DNLU National Moot Court Competition 2026

Publications

Comparative Energy Security – China and India

Setting Up a Fund in GIFT City, IFSC

Payment Services Provider (PSP) Licence in GIFT IFSC

Newsletters

DPDP Act: Key Compliance Updates

NCLAT on Shareholders’ Right to Challenge Resolution Plans

Tata Sons Restructuring: Can RBI Listing Norms Be Avoided?